Risks and limits of FTO Test

The FTO test is often marketed as a 'fat gene' test, but its predictive value is limited. FTO variants (e.g., rs9939609) are associated with higher BMI in GWAS, but the effect per allele is only about 0.4 kg/m² – a few kilograms. Individual prediction is weak because lifestyle, diet, and exercise have far greater influence. Moreover, many DTC tests are not clinically validated and provide no actionable guidance. A positive result does not guarantee overweight or obesity. The evidence comes from population-wide association studies, not from randomized interventions. Risks of the test include false reassurance or unnecessary worry. An FTO test alone is not suitable for health management; a comprehensive risk assessment should always include lifestyle and clinical parameters.